SCHEDULE 13G

Company

COSCIENS Biopharma Inc.

Filed

February 15, 2006

Accession Number

0001047469-06-002023

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →